Chronic Stable Angina Pectoris Clinical Trial
Official title:
The Microcirculatory Characteristics of the Heart and Lung Meridians: A Study of CSAP Patients and Healthy Adults
This study is designed to detect the microcirculatory characteristics of meridian phenomena by using an objective assessment tool and investigate the site specificity for the meridian-visceral association and surface-surface association between two specific meridians.
The Lung and Heart meridians are chosen as two specific studied meridians. Participants of
chronic stable angina pectoris (CSAP) and healthy volunteers will be enrolled.
120 participants will be included and divided into the healthy control group, chronic stable
angina pectoris (CSAP) group and healthy intervention group. Laser doppler flowmetry (LDF)
will be used to assess the microcirculatory characteristics of meridian phenomena for the
Heart and Lung meridians. The site specificity for the meridian-visceral association will be
investigated by comparing the microcirculatory difference between the Heart and Lung
meridians in the healthy control group and CSAP group. Besides, participants in the healthy
intervention group will receive two sessions of moxibustion in the Heart meridian and Lung
meridian respectively to explore the site specificity for the surface-surface association.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03914131 -
Clinical Trial Scheme of Xinnaoning Capsule
|
Phase 4 | |
Not yet recruiting |
NCT04264559 -
The Heat Transport Characteristics of the Heart and Lung Meridians: A Study of CSAP Patients and Healthy Adults
|
N/A | |
Recruiting |
NCT04041206 -
A Study on the Microcirculatory Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With Stable Angina Pectoris
|
||
Recruiting |
NCT04041245 -
A Study on the Metabolic Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With Stable Angina Pectoris
|
||
Recruiting |
NCT03789552 -
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
|
Phase 3 | |
Completed |
NCT02315976 -
Acute Episodes in Chronic Stable Angina: Assessment of the Use of the Coronary Vasodilator Propatyl Nitrate.
|
Phase 4 |